Gefitinib Pliva 250 mg filmom obložene tablete
| Name | Gefitinib Pliva 250 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-317459732 |
| Active Substance | gefitinib |
| Composition | jedna filmom obložena tableta sadrži 250 mg gefitiniba |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Teva Pharma S.L.U., Zaragoza, Španjolska Merckle GmbH, Blaubeuren, Njemačka Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 17.08.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/01 |
| Registration Number | 381-12-01/286-23-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EB01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
